Idiotype vaccination for Non-Hodgkin lymphoma-Reference-Cited by-同舟云学术

Idiotype vaccination for Non-Hodgkin lymphoma

Published:2016-02-03 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ossendorf Vera¹,Cornely Oliver²,Draube Andreas²,Monsef Ina³,Engert Andreas⁴,Skoetz Nicole³

Affiliation:

1. Medical Division; Clinical Trials Center Cologne; Herderstrasse 52 Cologne Germany 50931

2. University Hospital of Cologne; Department of Internal Medicine 1, Center of Integrated Oncology Köln Bonn; Kerpener Str. 62 Cologne Germany 50924

3. University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924

4. University Hospital of Cologne; Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924

Publisher

Wiley

Subject

Pharmacology (medical)

Reference49 articles.

1. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project;Armitage;Journal of Clinical Oncology,1998

2. Interferon-alpha for maintenance of follicular lymphoma;Baldo;Cochrane Database of Systematic Reviews

3. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma;Bendandi;Nature Medicine,1999

4. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab;Boye;Annals of Oncology,2003

5. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation;Colombat;Blood,2001